| Deler fremragende | 7,190,876 shares |
| Insideraktier | 801.656 shares |
| Insider ejerskab | 11,15 % |
| Total Insiders | 21 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Motus GI Holdings, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Abv, Llc - | 591.481 | 33.799 | |
| Ascent Biomedical Ventures II, L.P. - | 591.481 | 33.799 | |
|
Joseph Edelman
10% Owner -
|
2.660.542 | 152.031 | |
| Larry N Feinberg - | 0 | 0 | |
| David P Hochman Director - [D] | 291.669 | 16.667 | |
| Jacobs Gary E. Director - [D] | 771.289 | 44.074 | |
| Shervin J Korangy Director - [D] | 190.189 | 10.868 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Moran Timothy P. Chief Executive Officer, Director - [D] [O] | 657.701 | 37.583 | |
| Samuel R Md Nussbaum Director - [D] | 97.689 | 5.582 | |
| Sonja Nelson Director - [D] | 100.709 | 5.755 | |
|
Oracle Partners Lp
10% Owner -
|
0 | 0 | |
|
Orchestra BioMed Holdings, Inc.
10% Owner -
|
804.096 | 53.606 | |
|
Orchestra BioMed, Inc.
10% Owner -
|
4.000.000 | 228.571 | |
|
Orchestra MOTUS Co-Investment Partners, LLC
10% Owner -
|
2.189.860 | 125.135 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Orchestra Medical Ventures II GP, LLC - | 0 | 0 | |
|
Perceptive Advisors Llc
10% Owner -
|
2.660.542 | 152.031 | |
|
Perceptive Life Sciences Master Fund Ltd
10% Owner -
|
2.660.542 | 152.031 | |
| Mark Pomeranz President and COO, Director - [D] [O] | 259.857 | 14.849 | |
| Gary J Pruden Director - [D] | 263.116 | 15.035 | |
| Darren Sherman Director - [D] | 194.602 | 11.120 | |
| Andrew Lawrence Taylor Chief Financial Officer - [O] | 230.682 | 13.182 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i MOTS / Motus GI Holdings, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i MOTS / Motus GI Holdings, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-22 | 3 | Orchestra BioMed Holdings, Inc. | MOTS | Common Stock | D | 804.096 | ||||||||
| 2022-02-11 | 2022-02-10 | 4 | Nelson Sonja | MOTS | Stock Option (right to buy) | D | 0,46 | 50.000 | 50.000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 0,46 | 175.000 | 175.000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 175.000 | 657.701 | ||||||
| 2022-02-11 | 2022-02-10 | 4 | Taylor Andrew Lawrence | MOTS | Stock Option (right to buy) | D | 0,46 | 95.000 | 95.000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 95.000 | 230.682 | ||||||
| 2022-02-11 | 2022-02-10 | 4 | Pomeranz Mark | MOTS | Stock Option (right to buy) | D | 0,46 | 95.000 | 95.000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 95.000 | 259.857 | ||||||
| 2022-02-11 | 2022-02-10 | 4 | Hochman David P | MOTS | Stock Option (right to buy) | D | 0,46 | 50.000 | 50.000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Korangy Shervin J | MOTS | Stock Option (right to buy) | D | 0,46 | 50.000 | 50.000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Sherman Darren | MOTS | Stock Option (right to buy) | D | 0,46 | 50.000 | 50.000 | |||||
| 2022-02-11 | 2022-02-10 | 4 | Pruden Gary J | MOTS | Stock Option (right to buy) | D | 0,46 | 50.000 | 50.000 | |||||
| 2022-01-07 | 2022-01-05 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 90.521 | 194.602 | ||||||
| 2022-01-07 | 2022-01-05 | 4 | Nelson Sonja | MOTS | Common Stock, par value $0.0001 per share | D | 82.500 | 100.709 | ||||||
| 2022-01-07 | 2022-01-05 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 127.083 | 291.669 | ||||||
| 2022-01-07 | 2022-01-05 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 82.500 | 190.189 | ||||||
| 2022-01-07 | 2022-01-05 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 106.563 | 263.116 | ||||||
| 2021-11-22 | 2021-11-19 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 0,5106 | 2.000 | 1 | 135.682 | ||||
| 2021-11-22 | 2021-11-19 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 0,5108 | 4.000 | 2 | 164.857 | ||||
| 2021-11-22 | 2021-11-19 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 0,5214 | 10.000 | 5 | 482.701 | ||||
| 2021-06-23 | 2021-06-22 | 4 | Nelson Sonja | MOTS | Stock Option (right to buy) | D | 1,04 | 50.000 | 50.000 | |||||
| 2021-06-23 | 2021-06-22 | 4 | Nelson Sonja | MOTS | Common Stock, par value $0.0001 per share | D | 18.209 | 18.209 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 1,78 | 141.000 | 141.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 141.000 | 472.701 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Sherman Darren | MOTS | Stock Option (right to buy) | D | 1,78 | 30.000 | 30.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 22.191 | 104.081 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 30.000 | 81.890 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Pruden Gary J | MOTS | Stock Option (right to buy) | D | 1,78 | 30.000 | 30.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 26.124 | 156.553 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 30.000 | 130.429 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Stock Option (right to buy) | D | 1,78 | 30.000 | 30.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 20.225 | 97.689 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 30.000 | 77.464 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Taylor Andrew Lawrence | MOTS | Stock Option (right to buy) | D | 1,78 | 60.000 | 60.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 60.000 | 133.682 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Korangy Shervin J | MOTS | Stock Option (right to buy) | D | 1,78 | 30.000 | 30.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 20.225 | 107.689 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 30.000 | 87.464 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Hochman David P | MOTS | Stock Option (right to buy) | D | 1,78 | 40.000 | 40.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 32.472 | 164.586 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 40.000 | 132.114 | ||||||
| 2021-02-19 | 2021-02-17 | 4 | Pomeranz Mark | MOTS | Stock Option (right to buy) | D | 1,78 | 65.000 | 65.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 65.000 | 160.857 | ||||||
| 2021-02-05 | 2021-01-26 | 4 | FEINBERG LARRY N | MOTS | Common Stock | I | 1,9000 | -30.000 | -57 | 0 | ||||
| 2021-02-05 | 2021-01-26 | 4 | FEINBERG LARRY N | MOTS | Common Stock | I | 1,9034 | -29.115 | -55 | 105.885 | ||||
| 2021-01-22 | 2021-01-22 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 1,4800 | -550.000 | -814 | 2.660.542 | ||||
| 2021-01-22 | 2021-01-21 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 1,6800 | -674.352 | -1.133 | 3.210.542 | ||||
| 2021-01-22 | 2021-01-20 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 1,8000 | -325.648 | -586 | 3.884.894 | ||||
| 2021-01-14 | 2021-01-12 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 9.144 | 51.890 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 10.764 | 100.429 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 8.334 | 47.464 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 8.334 | 57.464 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 15.741 | 92.114 | ||||||
| 2020-12-18 | 2020-12-17 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 0,9700 | 3.000 | 3 | 42.746 | ||||
| 2020-12-10 | 2020-12-09 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 1,0800 | 1.000 | 1 | 95.857 | ||||
| 2020-12-10 | 2020-12-09 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 1,0800 | 1.000 | 1 | 73.682 | ||||
| 2020-12-07 | 2020-12-04 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 0,9930 | 5.000 | 5 | 76.373 | ||||
| 2020-12-07 | 2020-12-04 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 0,9644 | 10.000 | 10 | 331.701 | ||||
| 2020-11-13 | 2020-11-11 | 4 | Pomeranz Mark | MOTS | Stock Option (right to buy) | D | 0,74 | 75.000 | 75.000 | |||||
| 2020-11-13 | 2020-11-11 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 0,74 | 190.000 | 190.000 | |||||
| 2020-11-13 | 2020-11-11 | 4 | Taylor Andrew Lawrence | MOTS | Stock Option (right to buy) | D | 0,74 | 85.000 | 85.000 | |||||
| 2020-10-13 | 2020-10-12 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 9.430 | 49.130 | ||||||
| 2020-10-13 | 2020-10-12 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 9.430 | 39.130 | ||||||
| 2020-10-13 | 2020-10-12 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 11.132 | 89.665 | ||||||
| 2020-10-13 | 2020-10-12 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 10.346 | 39.746 | ||||||
| 2020-10-13 | 2020-10-12 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 18.466 | 71.373 | ||||||
| 2020-07-13 | 2020-07-10 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 14.600 | 52.907 | ||||||
| 2020-07-13 | 2020-07-10 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 7.200 | 39.700 | ||||||
| 2020-07-13 | 2020-07-10 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 7.700 | 78.533 | ||||||
| 2020-07-13 | 2020-07-10 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 7.900 | 29.400 | ||||||
| 2020-07-13 | 2020-07-10 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 7.200 | 29.700 | ||||||
| 2020-06-12 | 2020-06-11 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 1,17 | 200.000 | 200.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | Pomeranz Mark | MOTS | Stock Option (right to buy) | D | 1,17 | 80.000 | 80.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | Taylor Andrew Lawrence | MOTS | Stock Option (right to buy) | D | 1,17 | 90.000 | 90.000 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Hochman David P | MOTS | Stock Option (right to buy) | D | 2,16 | 20.000 | 20.000 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 20.000 | 38.307 | ||||||
| 2020-02-07 | 2019-12-31 | 4 | Hochman David P By NSH 2008 Family Trust | MOTS | Warrants (right to buy) | I | 5,00 | 2.019 | 2.019 | |||||
| 2020-02-07 | 2019-12-31 | 4 | Hochman David P By NSH 2008 Family Trust | MOTS | Warrants (right to buy) | I | 5,00 | 1.766 | 1.766 | |||||
| 2020-02-07 | 2019-12-31 | 4 | Hochman David P | MOTS | Warrants (right to buy) | D | 5,00 | 299 | 599 | |||||
| 2020-02-07 | 2019-12-31 | 4 | Hochman David P | MOTS | Warrants (right to buy) | D | 5,00 | 305 | 305 | |||||
| 2020-02-07 | 2020-02-06 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Stock Option (right to buy) | D | 2,16 | 12.500 | 12.500 | |||||
| 2020-02-07 | 2020-02-06 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 12.500 | 22.500 | ||||||
| 2020-02-07 | 2020-02-06 | 4 | Pruden Gary J | MOTS | Stock Option (right to buy) | D | 2,16 | 12.500 | 12.500 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 12.500 | 70.833 | ||||||
| 2020-02-07 | 2020-02-06 | 4 | Korangy Shervin J | MOTS | Stock Option (right to buy) | D | 2,16 | 12.500 | 12.500 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 12.500 | 32.500 | ||||||
| 2020-02-07 | 2020-02-06 | 4 | Sherman Darren | MOTS | Stock Option (right to buy) | D | 2,16 | 12.500 | 12.500 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 12.500 | 21.500 | ||||||
| 2020-02-07 | 2020-02-06 | 4 | Pomeranz Mark | MOTS | Stock Option (right to buy) | D | 2,16 | 40.336 | 40.336 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 40.336 | 94.857 | ||||||
| 2020-02-07 | 2020-02-06 | 4 | Taylor Andrew Lawrence | MOTS | Stock Option (right to buy) | D | 2,16 | 46.098 | 46.098 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 46.098 | 72.682 | ||||||
| 2020-02-07 | 2020-02-06 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 2,16 | 103.720 | 103.720 | |||||
| 2020-02-07 | 2020-02-06 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 103.720 | 321.701 | ||||||
| 2019-11-20 | 2019-11-20 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 1,5400 | 10.000 | 15 | 217.981 | ||||
| 2019-11-19 | 2019-11-18 | 4 | Jacobs Gary E. By Jacobs Investment Company | MOTS | Common Stock, par value $0.0001 per share | I | 1,5400 | 17.000 | 26 | 771.289 | ||||
| 2019-07-01 | 2019-06-27 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 3,0000 | 1.000.000 | 3.000 | 4.210.542 | ||||
| 2019-07-01 | 2019-07-01 | 4 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock | I | 2,9896 | 5.000 | 15 | 30.000 | ||||
| 2019-07-01 | 2019-07-01 | 4 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock | I | 3,0158 | 35.000 | 106 | 135.000 | ||||
| 2019-07-01 | 2019-06-27 | 4 | FEINBERG LARRY N | MOTS | Common Stock | I | 3,0000 | 25.000 | 75 | 25.000 | ||||
| 2019-07-01 | 2019-06-27 | 4 | FEINBERG LARRY N | MOTS | Common Stock | I | 3,0000 | 100.000 | 300 | 100.000 | ||||
| 2019-07-01 | 2019-06-27 | 4 | FEINBERG LARRY N | MOTS | Common Stock | I | 3,0000 | 138.698 | 416 | 550.698 | ||||
| 2019-07-01 | 2019-06-27 | 4 | FEINBERG LARRY N | MOTS | Common Stock | I | 3,0000 | 93.566 | 281 | 379.566 | ||||
| 2019-07-01 | 2019-06-27 | 4 | FEINBERG LARRY N | MOTS | Common Stock, par value $0.0001 per share ("Common Stock") | I | 3,0000 | 634.402 | 1.903 | 2.711.402 | ||||
| 2019-07-01 | 2019-07-01 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 3,0000 | 8.333 | 25 | 58.333 | ||||
| 2019-07-01 | 2019-07-01 | 4 | Hochman David P By DPH 2008 Trust | MOTS | Common Stock, par value $0.0001 per share | I | 3,0000 | 10.000 | 30 | 110.000 | ||||
| 2019-07-01 | 2019-07-01 | 4 | Jacobs Gary E. By Jacobs Investment Company LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3,0000 | 8.333 | 25 | 754.289 | ||||
| 2019-07-01 | 2019-07-01 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 3,0000 | 3.333 | 10 | 207.981 | ||||
| 2019-07-01 | 2019-07-01 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 3,0000 | 1.000 | 3 | 54.521 | ||||
| 2019-05-24 | 2019-05-22 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 3,3800 | 5.000 | 17 | 204.648 | ||||
| 2019-02-15 | 2019-02-13 | 4 | Sherman Darren | MOTS | Stock Option (right to buy) | D | 4,30 | 25.000 | 25.000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Hochman David P | MOTS | Stock Option (right to buy) | D | 4,30 | 40.000 | 40.000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Pruden Gary J | MOTS | Stock Option (right to buy) | D | 4,30 | 25.000 | 25.000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Korangy Shervin J | MOTS | Stock Option (right to buy) | D | 4,30 | 25.000 | 25.000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Stock Option (right to buy) | D | 4,30 | 25.000 | 25.000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Jacobs Gary E. | MOTS | Stock Option (right to buy) | D | 4,30 | 25.000 | 25.000 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Pomeranz Mark | MOTS | Stock Option (right to buy) | D | 4,30 | 128.641 | 128.641 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 42.880 | 53.521 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Taylor Andrew Lawrence | MOTS | Stock Option (right to buy) | D | 4,30 | 70.753 | 70.753 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 23.584 | 26.584 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 4,30 | 28.944 | 28.944 | |||||
| 2019-02-15 | 2019-02-13 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 174.648 | 199.648 | ||||||
| 2019-01-17 | 2018-12-24 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 2,7000 | 400.000 | 1.080 | 3.210.541 | ||||
| 2019-01-17 | 2018-02-14 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 5,0000 | 10.000 | 50 | 2.810.541 | ||||
| 2018-12-26 | 2018-12-24 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 2,7000 | 1.000 | 3 | 3.000 | ||||
| 2018-12-26 | 2018-12-24 | 4 | Hochman David P By DPH 2008 Trust | MOTS | Common Stock, par value $0.0001 per share | I | 2,7000 | 20.000 | 54 | 100.000 | ||||
| 2018-12-26 | 2018-12-24 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 2,7000 | 2.500 | 7 | 10.641 | ||||
| 2018-12-26 | 2018-12-24 | 4 | Jacobs Gary E. By Jacobs Investment Company | MOTS | Common Stock, par value $0.0001 per share | I | 2,7000 | 10.000 | 27 | 745.956 | ||||
| 2018-12-26 | 2018-12-24 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 2,7000 | 10.000 | 27 | 25.000 | ||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 3.187.000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 4.852.000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 3.061.000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 3.187.000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 4.852.000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 3.061.000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 3.187.000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 4.852.000 | ||||||||
| 2018-12-26 | 3 | FEINBERG LARRY N See Footnotes | MOTS | Common Stock, par value $0.0001 per share | I | 3.061.000 | ||||||||
| 2018-11-27 | 2018-11-27 | 4 | Jacobs Gary E. By Jacobs Investment Company | MOTS | Common Stock, par value $0.0001 per share | I | 3,4800 | 7.100 | 25 | 735.956 | ||||
| 2018-11-21 | 2018-11-19 | 4 | Moran Timothy P. | MOTS | Common Stock, par value $0.0001 per share | D | 3,4800 | 15.000 | 52 | 15.000 | ||||
| 2018-11-21 | 2018-11-16 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 3,4900 | 15.000 | 52 | 18.000 | ||||
| 2018-11-09 | 2018-11-08 | 4 | Moran Timothy P. | MOTS | Stock Option (right to buy) | D | 3,78 | 495.000 | 495.000 | |||||
| 2018-06-11 | 3 | Orchestra BioMed, Inc. | MOTS | Common Stock, par value $0.0001 per share | D | 4.000.000 | ||||||||
| 2018-06-11 | 3 | Orchestra BioMed, Inc. | MOTS | Common Stock, par value $0.0001 per share | D | 4.000.000 | ||||||||
| 2018-06-11 | 3 | Orchestra BioMed, Inc. | MOTS | Common Stock, par value $0.0001 per share | D | 4.000.000 | ||||||||
| 2018-06-04 | 2018-05-31 | 4 | Hochman David P By Orchestra BioMed, Inc. | MOTS | Common Stock, par value $0.0001 per share | I | 2.000.000 | 2.000.000 | ||||||
| 2018-06-04 | 2018-05-31 | 4 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | -1.000.000 | 109.792 | ||||||
| 2018-06-04 | 2018-05-31 | 4 | Sherman Darren By Orchestra BioMed, Inc. | MOTS | Common Stock, par value $0.0001 per share | I | 2.000.000 | 2.000.000 | ||||||
| 2018-06-04 | 2018-05-31 | 4 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | -1.000.000 | 109.792 | ||||||
| 2018-06-04 | 2018-05-31 | 4 | Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | D | -1.000.000 | 591.481 | ||||||
| 2018-06-04 | 2018-05-31 | 4 | ABV, LLC By Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | -1.000.000 | 591.481 | ||||||
| 2018-05-21 | 2018-05-18 | 4 | Jacobs Gary E. By Jacobs Investment Company | MOTS | Common Stock, par value $0.0001 per share | I | 5,2400 | 5.000 | 26 | 728.856 | ||||
| 2018-05-21 | 2018-05-17 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 5,5500 | 1.000 | 6 | 9.000 | ||||
| 2018-05-21 | 2018-05-17 | 4 | Hochman David P By DPH 2008 Trust | MOTS | Common Stock, par value $0.0001 per share | I | 5,4900 | 5.000 | 27 | 80.000 | ||||
| 2018-03-28 | 2018-03-27 | 4 | Pruden Gary J | MOTS | Stock Option (right to buy) | D | 4,58 | 50.000 | 50.000 | |||||
| 2018-02-21 | 3/A | Sherman Darren By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 1.094.930 | ||||||||
| 2018-02-21 | 3/A | Hochman David P By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 1.094.930 | ||||||||
| 2018-02-21 | 3/A | Orchestra Medical Ventures II GP, LLC By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 0 | ||||||||
| 2018-02-21 | 2018-02-16 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Warrant (right to buy) | I | 5,00 | 180.055 | 180.055 | |||||
| 2018-02-21 | 2018-02-16 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Series A Convertible Preferred Stock | I | -256.386 | 0 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 5,0000 | 1.000.000 | 5.000 | 2.800.541 | ||||
| 2018-02-21 | 2018-02-16 | 4 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 256.386 | 1.800.541 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Warrants (right to buy) | I | 5,00 | 115.997 | 115.997 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Warrants (right to buy) | I | 5,00 | 106.980 | 106.980 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P | MOTS | Warrants (right to buy) | D | 5,00 | 300 | 300 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Series A Convertible Preferred Stock | I | 0,00 | -65.038 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Series A Convertible Preferred Stock | I | 0,00 | -99.748 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P | MOTS | Series A Convertible Preferred Stock | D | 0,00 | -750 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 65.038 | 1.159.968 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 99.748 | 1.109.792 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 5,0000 | 40.000 | 200 | 1.010.044 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 750 | 78.000 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 75.000 | 375 | 77.250 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Pruden Gary J | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 50.000 | 250 | 50.000 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Jacobs Gary E. By Jacobs Investment Company LLC | MOTS | Warrant (right to buy) | I | 5,00 | 72.386 | 72.386 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Jacobs Gary E. By Jacobs Investment Company LLC | MOTS | Series A Convertible Preferred Stock | I | 0,00 | -63.289 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Jacobs Gary E. By Jacobs Investment Company LLC | MOTS | Common Stock, par value $0.0001 per share | I | 63.289 | 723.856 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Jacobs Gary E. | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 5.000 | 25 | 9.100 | ||||
| 2018-02-21 | 2018-02-16 | 4 | NUSSBAUM SAMUEL R MD | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 10.000 | 50 | 10.000 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Warrants (right to buy) | I | 5,00 | 115.997 | 115.997 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Warrants (right to buy) | I | 5,00 | 106.980 | 106.980 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren | MOTS | Warrants (right to buy) | D | 5,00 | 300 | 300 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Series A Convertible Preferred Stock | I | 0,00 | -65.038 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Series A Convertible Preferred Stock | I | 0,00 | -99.748 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren | MOTS | Series A Convertible Preferred Stock | D | 0,00 | -750 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 65.038 | 1.159.968 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 99.748 | 1.109.792 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 5,0000 | 40.000 | 200 | 1.010.044 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 750 | 8.000 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 5.000 | 25 | 7.250 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 8.000 | 40 | 8.141 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Ascent Biomedical Ventures II, L.P. | MOTS | Warrant (right to buy) | D | 5,00 | 159.149 | 159.149 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Ascent Biomedical Ventures II, L.P. | MOTS | Series A Convertible Preferred Stock | D | 0,00 | -144.352 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | D | 144.352 | 1.591.481 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | Taylor Andrew Lawrence | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 2.000 | 10 | 2.000 | ||||
| 2018-02-21 | 2018-02-16 | 4 | Korangy Shervin J | MOTS | Common Stock, par value $0.0001 per share | D | 5,0000 | 20.000 | 100 | 20.000 | ||||
| 2018-02-21 | 2018-02-16 | 4 | ABV, LLC By Ascent Biomedical Ventures Synecor, L.P. | MOTS | Warrant (right to buy) | I | 5,00 | 61.125 | 61.125 | |||||
| 2018-02-21 | 2018-02-16 | 4 | ABV, LLC By Ascent Biomedical Ventures II, L.P. | MOTS | Warrant (right to buy) | I | 5,00 | 159.149 | 159.149 | |||||
| 2018-02-21 | 2018-02-16 | 4 | ABV, LLC By Ascent Biomedical Ventures Synecor, L.P. | MOTS | Series A Convertible Preferred Stock | I | 0,00 | -26.241 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | ABV, LLC By Ascent Biomedical Ventures II, L.P. | MOTS | Series A Convertible Preferred Stock | I | 0,00 | -144.352 | 0 | |||||
| 2018-02-21 | 2018-02-16 | 4 | ABV, LLC By Ascent Biomedical Ventures Synecor, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 26.241 | 611.241 | ||||||
| 2018-02-21 | 2018-02-16 | 4 | ABV, LLC By Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 144.352 | 1.591.481 | ||||||
| 2018-02-13 | 3 | Sherman Darren By Accelerated Technologies, Inc. | MOTS | Common Stock, par value $0.0001 per share | I | 2.253.572 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Orchestra Medical Ventures II Reserve, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2.285.426 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3.172.118 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3.297.004 | ||||||||
| 2018-02-13 | 3 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 2.204.324 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3.172.118 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3.297.004 | ||||||||
| 2018-02-13 | 3 | Sherman Darren | MOTS | Common Stock, par value $0.0001 per share | D | 2.204.324 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Accelerated Technologies, Inc. | MOTS | Common Stock, par value $0.0001 per share | I | 2.253.572 | ||||||||
| 2018-02-13 | 3 | Sherman Darren By Orchestra Medical Ventures II Reserve, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2.285.426 | ||||||||
| 2018-02-13 | 3 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 282 | ||||||||
| 2018-02-13 | 3 | Pomeranz Mark | MOTS | Common Stock, par value $0.0001 per share | D | 282 | ||||||||
| 2018-02-13 | 3 | Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | D | 2.894.258 | ||||||||
| 2018-02-13 | 3 | Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | D | 2.894.258 | ||||||||
| 2018-02-13 | 3 | Orchestra Medical Ventures II GP, LLC By Orchestra Medical Ventures II Reserve, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2.231.678 | ||||||||
| 2018-02-13 | 3 | Orchestra Medical Ventures II GP, LLC By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3.118.370 | ||||||||
| 2018-02-13 | 3 | Orchestra Medical Ventures II GP, LLC By Orchestra Medical Ventures II Reserve, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2.231.678 | ||||||||
| 2018-02-13 | 3 | Orchestra Medical Ventures II GP, LLC By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3.243.256 | ||||||||
| 2018-02-13 | 3 | Orchestra Medical Ventures II GP, LLC By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3.118.370 | ||||||||
| 2018-02-13 | 3 | Orchestra Medical Ventures II GP, LLC By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3.243.256 | ||||||||
| 2018-02-13 | 3 | Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | D | 2.189.860 | ||||||||
| 2018-02-13 | 3 | Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | D | 2.189.860 | ||||||||
| 2018-02-13 | 3 | Jacobs Gary E. By Jacobs Investment Company LLC | MOTS | Common Stock, par value $0.0001 per share | I | 1.325.234 | ||||||||
| 2018-02-13 | 3 | Jacobs Gary E. | MOTS | Common Stock, par value $0.0001 per share | D | 668.767 | ||||||||
| 2018-02-13 | 3 | Jacobs Gary E. By Jacobs Investment Company LLC | MOTS | Common Stock, par value $0.0001 per share | I | 1.325.234 | ||||||||
| 2018-02-13 | 3 | Jacobs Gary E. | MOTS | Common Stock, par value $0.0001 per share | D | 668.767 | ||||||||
| 2018-02-13 | 3 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 3.088.310 | ||||||||
| 2018-02-13 | 3 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 3.088.310 | ||||||||
| 2018-02-13 | 3 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 3.088.310 | ||||||||
| 2018-02-13 | 3 | PERCEPTIVE ADVISORS LLC | MOTS | Common Stock | I | 3.088.310 | ||||||||
| 2018-02-13 | 3 | ABV, LLC By Ascent Biomedical Ventures Synecor, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2.617.129 | ||||||||
| 2018-02-13 | 3 | ABV, LLC By Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3.479.258 | ||||||||
| 2018-02-13 | 3 | ABV, LLC By Ascent Biomedical Ventures Synecor, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2.617.129 | ||||||||
| 2018-02-13 | 3 | ABV, LLC By Ascent Biomedical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3.479.258 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3.297.004 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Orchestra Medical Ventures II Reserve, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2.285.426 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Accelerated Technologies, Inc. | MOTS | Common Stock, par value $0.0001 per share | I | 2.253.572 | ||||||||
| 2018-02-13 | 3 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 2.204.324 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3.172.118 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Orchestra Medical Ventures II Reserve, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 2.285.426 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Orchestra MOTUS Co-Investment Partners, LLC | MOTS | Common Stock, par value $0.0001 per share | I | 3.297.004 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Accelerated Technologies, Inc. | MOTS | Common Stock, par value $0.0001 per share | I | 2.253.572 | ||||||||
| 2018-02-13 | 3 | Hochman David P | MOTS | Common Stock, par value $0.0001 per share | D | 2.204.324 | ||||||||
| 2018-02-13 | 3 | Hochman David P By Orchestra Medical Ventures II, L.P. | MOTS | Common Stock, par value $0.0001 per share | I | 3.172.118 |
